Advertisement

Cancer Causes & Control

, Volume 30, Issue 4, pp 395–408 | Cite as

Enrollment and biospecimen collection in a multiethnic family cohort: the Northern California site of the Breast Cancer Family Registry

  • Esther M. JohnEmail author
  • Meera Sangaramoorthy
  • Jocelyn Koo
  • Alice S. Whittemore
  • Dee W. West
Original Paper
  • 50 Downloads

Abstract

Purpose

Racial/ethnic minorities are often assumed to be less willing to participate in and provide biospecimens for biomedical research. We examined racial/ethnic differences in enrollment of women with breast cancer (probands) and their first-degree relatives in the Northern California site of the Breast Cancer Family Registry from 1996 to 2011.

Methods

We evaluated participation in several study components, including biospecimen collection, for probands and relatives by race/ethnicity, cancer history, and other factors.

Results

Of 4,780 eligible probands, 76% enrolled in the family registry by completing the family history and risk factor questionnaires and 68% also provided a blood or mouthwash sample. Enrollment was highest (81%) for non-Hispanic whites (NHWs) and intermediate (73–76%) for Hispanics, African Americans, and all Asian American subgroups, except Filipina women (66%). Of 4,279 eligible relatives, 77% enrolled in the family registry, and 65% also provided a biospecimen sample. Enrollment was highest for NHWs (87%) and lowest for Chinese (68%) and Filipinas (67%). Among those enrolled, biospecimen collection rates were similar for NHW, Hispanic, and African American women, both for probands (92–95%) and relatives (82–87%), but lower for some Asian–American subgroups (probands: 72–88%; relatives: 71–88%), foreign-born Asian Americans, and probands those who were more recent immigrants or had low English language proficiency.

Conclusions

These results show that racial/ethnic minority populations are willing to provide biospecimen samples for research, although some Asian American subgroups in particular may need more directed recruitment methods. To address long-standing and well-documented cancer health disparities, minority populations need equal opportunities to contribute to biomedical research.

Keywords

Biospecimen collection Study participation Race/ethnicity Breast cancer Epidemiology Hispanics African Americans Asian Americans 

Abbreviations

CI

Confidence interval

NHW

Non-Hispanic white

OR

Odds ratio

SES

Socioeconomic status

SFBCS

San Francisco Bay Area Breast Cancer Study

U.S.

United States

Notes

Acknowledgments

We thank the study coordinators, data managers, analysts, interviewers, and phlebotomists who supported the family registry study, including Enid Satariano, Connie Cady, and Judy Goldstein. We are grateful to the families who continue to participate in the family registry study.

Author contributions

EMJ acquired the data, conceived of and designed the analysis, interpreted the data, and drafted and revised the manuscript. MS contributed to the literature review and the writing. JK and MS performed data management and the statistical analysis, interpreted the data, and participated in the revision of the manuscript. ASW and DWW acquired the data, interpreted the data, and participated in the revision of the manuscript. All authors approved the final manuscript.

Funding

This work was supported by the National Cancer Institute at the National Institutes of Health (Grant UM1 CA164920). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government or the Breast Cancer Family Registry. The collection of cancer incidence data used in these studies was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Sect. 103885; the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program under contract HHSN261201000036C awarded to the Cancer Prevention Institute of California; and the Centers for Disease Control and Prevention’s National Program of Cancer Registries, under agreement #1U58 DP000807-01 awarded to the Public Health Institute.

Compliance with ethical standards

Conflict of interest

The authors declare they have no conflicts of interest.

Ethical approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the Institutional Review Board at the Cancer Prevention Institute of California and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in this study.

Supplementary material

10552_2019_1154_MOESM1_ESM.docx (29 kb)
Supplementary material 1 (DOCX 24 KB)

References

  1. 1.
    Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, Henley SJ, Eheman CR, Anderson RN, Penberthy L (2015) Annual Report to the Nation on the Status of Cancer, 1975–2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst 107(6):djv048Google Scholar
  2. 2.
    Hunt BR, Hurlbert MS (2016) Black:white disparities in breast cancer mortality in the 50 largest cities in the United States, 2005–2014. Cancer Epidemiol 45:169–173Google Scholar
  3. 3.
    Wheeler SB, Reeder-Hayes KE, Carey LA (2013) Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist 18(9):986–993Google Scholar
  4. 4.
    Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, Patmios G, Hiatt RA (2008) Approaching health disparities from a population perspective: the National Institutes of health centers for population health and health disparities. Am J Public Health 98(9):1608–1615Google Scholar
  5. 5.
    Martin DN, Lam TK, Brignole K, Ashing KT, Blot WJ, Burhansstipanov L, Chen JT, Dignan M, Gomez SL, Martinez ME, Matthews A, Palmer JR, Perez-Stable EJ, Schootman M, Vilchis H, Vu A, Srinivasan S (2016) Recommendations for cancer epidemiologic research in understudied populations and implications for future needs. Cancer Epidemiol Biomarkers Prev 25(4):573–580Google Scholar
  6. 6.
    Aziz NM, Rowland JH (2002) Cancer survivorship research among ethnic minority and medically underserved groups. Oncol Nurs Forum 29(5):789–801Google Scholar
  7. 7.
    Chen MS Jr, Lara PN, Dang JH, Paterniti DA, Kelly K (2014) Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials. Cancer 120:1091–1096Google Scholar
  8. 8.
    Nicholson LM, Schwirian PM, Groner JA (2015) Recruitment and retention strategies in clinical studies with low-income and minority populations: progress from 2004 to 2014. Contemp Clin Trials 45(Pt A):34–40Google Scholar
  9. 9.
    Simon MA, de la Riva EE, Bergan R, Norbeck C, McKoy JM, Kulesza P, Dong X, Schink J, Fleisher L (2014) Improving diversity in cancer research trials: the story of the Cancer Disparities Research Network. J Cancer Educ 29(2):366–374Google Scholar
  10. 10.
    Tham HM, Hohl S, Copeland W, Briant KJ, Marquez-Magana L, Thompson B (2017) Enhancing biospecimen knowledge among health care providers and representatives from community organizations. Health Promot Pract 18(5):715–725Google Scholar
  11. 11.
    Wendler D, Kington R, Madans J, Wye GV, Christ-Schmidt H, Pratt LA, Brawley OW, Gross CP, Emanuel E (2006) Are racial and ethnic minorities less willing to participate in health research. PLoS Med 3(2):e19Google Scholar
  12. 12.
    Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242Google Scholar
  13. 13.
    James RD, Yu JH, Henrikson NB, Bowen DJ, Fullerton SM (2008) Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet 11(4):241–249Google Scholar
  14. 14.
    Dang JH, Rodriguez EM, Luque JS, Erwin DO, Meade CD, Chen MS Jr (2014) Engaging diverse populations about biospecimen donation for cancer research. J Commun Genet 5(4):313–327Google Scholar
  15. 15.
    Hann KEJ, Freeman M, Fraser L, Waller J, Sanderson SC, Rahman B, Side L, Gessler S, Lanceley A, team Ps (2017) Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health 17(1):503Google Scholar
  16. 16.
    Thompson B, Hebert JR (2014) Involving disparate populations in clinical trials and biobanking protocols: experiences from the community network program centers. Cancer Epidemiol Biomarkers Prev 23(3):370–373Google Scholar
  17. 17.
    Partridge EE (2014) Yes, minority and underserved populations will participate in biospecimen collection. Cancer Epidemiol Biomarkers Prev 23(6):895–897Google Scholar
  18. 18.
    Hagiwara N, Berry-Bobovski L, Francis C, Ramsey L, Chapman RA, Albrecht TL (2014) Unexpected findings in the exploration of African American underrepresentation in biospecimen collection and biobanks. J Cancer Educ 29(3):580–587Google Scholar
  19. 19.
    John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O’Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D (2004) The breast cancer family registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6(4):R375–R389Google Scholar
  20. 20.
    Terry MB, Phillips KA, Daly MB, John EM, Andrulis IL, Buys SS, Goldgar DE, Knight JA, Whittemore AS, Chung WK, Apicella C, Hopper JL (2016) Cohort profile: the breast cancer prospective family study cohort (ProF-SC). Int J Epidemiol 45(3):683–692Google Scholar
  21. 21.
    Hopper JL, Bishop DT, Easton DF (2005) Population-based family studies in genetic epidemiology. Lancet 366(9494):1397–1406Google Scholar
  22. 22.
    Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12(8):703–711Google Scholar
  23. 23.
    John EM, Phipps AI, Davis A, Koo J (2005) Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 14(12):2905–2913Google Scholar
  24. 24.
    John EM, Schwartz GG, Koo J, Wang W, Ingles SA (2007) Sun exposure, vitamin D receptor gene polymorphisms and breast cancer risk in a multiethnic population. Am J Epidemiol 166(12):1409–1419Google Scholar
  25. 25.
    Signorello LB, Hargreaves MK, Blot WJ (2010) The Southern community cohort study: investigating health disparities. J Health Care Poor Underserved 21(1 Suppl):26–37Google Scholar
  26. 26.
    Bussey-Jones J, Garrett J, Henderson G, Moloney M, Blumenthal C, Corbie-Smith G (2010) The role of race and trust in tissue/blood donation for genetic research. Genet Med 12(2):116–121Google Scholar
  27. 27.
    Adams-Campbell LL, Dash C, Palmer JR, Wiedemeier MV, Russell CW, Rosenberg L, Cozier YC (2016) Predictors of biospecimen donation in the black women’s health study. Cancer Causes Control 27(6):797–803Google Scholar
  28. 28.
    Cozier YC, Albert MA, Castro-Webb N, Coogan PF, Ridker P, Kaufman HW, Palmer JR, Rosenberg L (2016) Neighborhood socioeconomic status in relation to serum biomarkers in the black women’s health study. J Urban Health 93(2):279–291Google Scholar
  29. 29.
    Lacey JV Jr, Savage KE (2016) 50% Response rates: half-empty, or half-full. Cancer Causes Control 27(6):805–808Google Scholar
  30. 30.
    Lopez DS, Fernandez ME, Cano MA, Mendez C, Tsai CL, Wetter DW, Strom SS (2014) Association of acculturation, nativity, and years living in the United States with biobanking among individuals of Mexican descent. Cancer Epidemiol Biomarkers Prev 23(3):402–408Google Scholar
  31. 31.
    Gabriel A, Cohen CC, Sun C (2014) Consent to specimen storage and continuing studies by race and ethnicity: a large dataset analysis using the 2011–2012 National Health and Nutrition Examination Survey. Sci World J 2014:120891Google Scholar
  32. 32.
    Loffredo CA, Luta G, Wallington S, Makgoeng SB, Selsky C, Mandelblatt JS, Adams-Campbell LL (2013) Region 1 Bio-specimen management of cancer health disparities. Knowledge and willingness to provide research biospecimens among foreign-born Latinos using safety-net clinics. J Commun Health 38(4):652–659Google Scholar
  33. 33.
    Hohl SD, Gonzalez C, Carosso E, Ibarra G, Thompson B (2014) I did it for us and I would do it again: perspectives of rural latinos on providing biospecimens for research. Am J Public Health 104(5):911–916Google Scholar
  34. 34.
    Ceballos RM, Knerr S, Scott MA, Hohl SD, Malen RC, Vilchis H, Thompson B (2014) Latino beliefs about biomedical research participation: a qualitative study on the U.S.-Mexico border. J Empir Res Hum Res Ethics 9(4):10–21Google Scholar
  35. 35.
    Rodriguez EM, Saad-Harfouche FG, Miller A, Mahoney MC, Ambrosone CB, Morrison CD, Underwood WR, Erwin DO (2016) Engaging diverse populations in biospecimen donation: results from the Hoy y Manana study. J Community Genet 7(4):271–277Google Scholar
  36. 36.
    Nodora JN, Komenaka IK, Bouton ME, Ohno-Machado L, Schwab R, Kim HE, Farcas C, Perez G, Elena Martinez M (2017) Biospecimen sharing among Hispanic women in a safety-net clinic: implications for the precision medicine initiative. J Natl Cancer Inst 109 (2)Google Scholar
  37. 37.
    Wenzel L, Bowen D, Habbal R, Leighton N, Vu T, Anton-Culver H (2008) Testing targeted approaches to enhance cancer genetics network minority recruitment within Asian populations. Commun Genet 11(4):234–240Google Scholar
  38. 38.
    Gao W, Ma GX, Tan Y, Fang C, Weaver J, Jin M, Lai P (2014) Factors associated with willingness to participate in biospecimen research among Chinese Americans. Biopreserv Biobank 12(2):131–138Google Scholar
  39. 39.
    Tong EK, Fung LC, Stewart SL, Paterniti DA, Dang JH, Chen MS Jr (2014) Impact of a biospecimen collection seminar on willingness to donate biospecimens among Chinese Americans: results from a randomized, controlled community-based trial. Cancer Epidemiol Biomarkers Prev 23(3):392–401Google Scholar
  40. 40.
    Gao W, Ma GX, Tan Y, Fang C, Weaver J, Jin M, Lai P, Godwin AK (2014) Culturally appropriate education intervention on biospecimen research participation among Chinese Americans. Cancer Epidemiol Biomarkers Prev 23(3):383–391Google Scholar
  41. 41.
    Ma GX, Tan Y, Blakeney NC, Seals BF, Ma XS, Zhai S, Liu A, Tai Y, Michaels M (2014) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Biomarkers Prev 23(3):424–432Google Scholar
  42. 42.
    McQuillan GM, Pan Q, Porter KS (2006) Consent for genetic research in a general population: an update on the National Health and Nutrition Examination Survey experience. Genet Med 8(6):354–360Google Scholar
  43. 43.
    Brown DR, Fouad MN, Basen-Engquist K, Tortolero-Luna G (2000) Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol 10(8 Suppl):S13–S21Google Scholar
  44. 44.
    Hughes C, Peterson SK, Ramirez A, Gallion KJ, McDonald PG, Skinner CS, Bowen D (2004) Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 13(7):1146–1155Google Scholar
  45. 45.
    Brown BA, Long HL, Gould H, Weitz T, Milliken N (2000) A conceptual model for the recruitment of diverse women into research studies. J Womens Health Gend Based Med 9(6):625–632Google Scholar
  46. 46.
    Paskett ED, Reeves KW, McLaughlin JM, Katz ML, McAlearney AS, Ruffin MT, Halbert CH, Merete C, Davis F, Gehlert S (2008) Recruitment of minority and underserved populations in the United States: the centers for population health and health disparities experience. Contemp Clin Trials 29(6):847–861Google Scholar
  47. 47.
    Greiner KA, Friedman DB, Adams SA, Gwede CK, Cupertino P, Engelman KK, Meade CD, Hebert JR (2014) Effective recruitment strategies and community-based participatory research: community networks program centers’ recruitment in cancer prevention studies. Cancer Epidemiol Biomarkers Prev 23(3):416–423Google Scholar
  48. 48.
    Wallington SF, Dash C, Sheppard VB, Goode TD, Oppong BA, Dodson EE, Hamilton RN, Adams-Campbell LL (2016) Enrolling minority and underserved populations in cancer clinical research. Am J Prev Med 50(1):111–117Google Scholar
  49. 49.
    Giuliano AR, Mokuau N, Hughes C, Tortolero-Luna G, Risendal B, Ho RCS, Prewitt TE, McCaskill-Stevens WJ (2000) Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 10(8 Suppl):S22–S34Google Scholar
  50. 50.
    Salman A, Nguyen C, Lee YH, Cooksey-James T (2016) A review of barriers to minorities’ participation in cancer clinical trials: implications for future cancer research. J Immigr Minor Health 18(2):447–453.  https://doi.org/10.1007/s10903-015-0198-9 Google Scholar
  51. 51.
    Dash C, Wallington SF, Muthra S, Dodson E, Mandelblatt J, Adams-Campbell LL (2014) Disparities in knowledge and willingness to donate research biospecimens: a mixed-methods study in an underserved urban community. J Commun Genet 5(4):329–336Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Cancer Prevention Institute of CaliforniaFremontUSA
  2. 2.Department of Medicine, Division of OncologyStanford University School of MedicineStanfordUSA
  3. 3.Stanford Cancer InstituteStanford University School of MedicineStanfordUSA
  4. 4.Department of Health Research and PolicyStanford University of School of MedicineStanfordUSA
  5. 5.Department of Biomedical Data ScienceStanford University of School of MedicineStanfordUSA
  6. 6.Stanford Cancer InstituteStanfordUSA

Personalised recommendations